Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome

Critical Reviews in Clinical Laboratory Sciences
Ancuta JurjIoana Berindan-Neagoe

Abstract

Even if considered a cumulative and not a proliferative CD5+ B-cell neoplasm, chronic lymphocytic leukemia (CLL) has a proliferation rate higher than that recognized earlier, especially in the lymphoid tissues. Some patients with CLL develop a clinical syndrome entitled Richter syndrome (RS). Understanding CLL genetics and epigenetics may help to elucidate the molecular basics of the clinical heterogeneity of this type of malignancy. In the present project we aimed to identify a microRNA species that can predict the evolution of therapy-resistant CLL towards RS. In the first phase of our study, microRNA-19b was identified as a possible target, and in the second phase, we transfected three different CLL cell lines with microRNA-19b mimic and inhibitor and assessed the potential role on leukemia cells in vitro. The mechanism by which miR-19b acts were identified as the upregulation of Ki67 and downregulation of p53. This was further supported through RT-PCR and western blotting on CLL cell lines, as well as by next generation sequencing on two patients diagnosed with CLL that evolved into RS.

References

Sep 26, 1992·Journal of the National Cancer Institute·L B TravisJ F Fraumeni
Nov 1, 1986·Cancer·J M McDonnellR B Mann
Aug 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·R GitterG K Jett
Jan 1, 1998·European Journal of Haematology·N NakamuraM Abe
Jan 9, 1998·The American Journal of Surgical Pathology·M BonatoC De Wolf-Peeters
Apr 1, 1998·Nature·D P CahillB Vogelstein
Aug 23, 2002·Nature·René Bernards, Robert A Weinberg
Oct 23, 2004·International Journal of Cancer. Journal International Du Cancer·Anna Janowska-WieczorekMariusz Z Ratajczak
Dec 4, 2004·Cancer·Apostolia-Maria Tsimberidou, Michael J Keating
Oct 28, 2005·The New England Journal of Medicine·George Adrian CalinCarlo M Croce
Sep 30, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tait D ShanafeltGordon W Dewald
Mar 25, 2008·Lancet·G Dighiero, T J Hamblin
Oct 6, 2009·The Journal of Biological Chemistry·Isabella ParoliniStefano Fais
Dec 4, 2009·Nature Reviews. Cancer·Thorsten ZenzStephan Stilgenbauer
Jun 10, 2010·Biochemical and Biophysical Research Communications·Hwan Myung LeeYong Song Gho
Jul 14, 2010·Best Practice & Research. Clinical Haematology·M T S BertilaccioF Caligaris-Cappio
Sep 15, 2010·The Journal of Cell Biology·Arthit ChairoungduaMichael J Caplan
Jan 6, 2011·JAMA : the Journal of the American Medical Association·Muller FabbriCarlo M Croce
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David GonzalezGareth J Morgan
Jul 29, 2011·International Journal of Cancer. Journal International Du Cancer·Davide RossiGianluca Gaidano
Dec 14, 2011·The New England Journal of Medicine·Lili WangCatherine J Wu
Dec 14, 2011·Hematology·Elaine S Jaffe, Stefania Pittaluga
Feb 3, 2012·Leukemia·S PospisilovaUNKNOWN European Research Initiative on CLL (ERIC)
Feb 7, 2012·European Journal of Medicinal Chemistry·Natalia MiklášováEvamarie Hey-Hawkins
Apr 3, 2012·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Sumitaka YamanakaFlorin M Selaru
Apr 17, 2012·British Journal of Haematology·Krzysztof JamroziakTadeusz Robak
Oct 16, 2013·The Journal of Experimental Medicine·Giulia FabbriRiccardo Dalla-Favera
Feb 6, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ling LiFlorin M Selaru
Mar 29, 2014·Nature·Robin AnderssonAlbin Sandelin
Jun 1, 2014·Cancer Biomarkers : Section a of Disease Markers·Sergiu SusmanIoana Berindan-Neagoe
Jun 12, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Massimo NegriniAntonino Neri

❮ Previous
Next ❯

Citations

Feb 14, 2019·American Journal of Physiology. Renal Physiology·In O Sun, Lilach O Lerman
May 11, 2019·Cells·Gavriela FeketeaMihnea T Zdrenghea
Aug 9, 2019·Journal of Clinical Medicine·Valentina SasUNKNOWN Romanian-Japanese Working Group of the Romanian Society for Bone Marrow Transplantation
Sep 6, 2020·Journal of Cellular and Molecular Medicine·Patric TeodorescuCiprian Tomuleasa
May 3, 2019·Critical Reviews in Clinical Laboratory Sciences·Valentina SasCiprian Tomuleasa
Jul 23, 2020·Frontiers in Oncology·Cristina TurcasCiprian Tomuleasa
Nov 5, 2019·Frontiers in Oncology·Alina-Andreea ZimtaIoana Berindan-Neagoe
Sep 18, 2020·International Journal of Molecular Sciences·Linda FabrisGeorge Calin
Mar 7, 2021·Pharmaceuticals·Marcello Francesco LinguaAlessandro Morotti
Apr 16, 2021·Current Oncology Reports·Maria Montserrat Aguilar-HernandezGabriela Galicia Garcia
Jul 23, 2021·Cell Biology International·Maedeh MasoumipourSeyed Hadi Mousavi
Aug 8, 2021·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Andrei StefancuCiprian Tomuleasa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.